EUVIMEDEUVIMED entdecken
Crossref

Indoxyl sulfate exacerbates alveolar bone loss in chronic kidney disease through ferroptosis

Huiwen Chen iD, Yining Zhou, Yingli Liu, Wei Zhou, Lina Xu, Dihua Shang, Jing Ni, Zhongchen Song

Oral Diseases · 2025

DOI: 10.1111/odi.15050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oral Diseases, 2025. Verfasst von Huiwen Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Alveolar Bone Loss, Ferroptosis, Indican, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: The National Natural Science Foundation of China, The Clinical Research Program of Health Care Industry, Shanghai Municipal Health Commission, The Data Sharing and Duplicated RCTs in Clinical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The purpose of this study was to determine whether indoxyl sulfate (IS) is involved in alveolar bone deterioration and to elucidate the mechanism underlying alveolar bone loss in chronic kidney disease (CKD) patients. Materials and Methods Mice were divided into the control group, CP group (ligature‐induced periodontitis), CKD group (5/6 nephrectomy), and CKD + CP group. The concentration of IS in the gingival crevicular fluid (GCF) was determined by HPLC. The bone microarchitecture was evaluated by micro‐CT. MC3T3‐E1 cells were stimulated with IS, and changes in mitochondrial morphology and ferroptosis‐related factors were detected. RT‐PCR, western blotting, alkaline phosphatase activity assays, and alizarin red S staining were utilized to assess how IS affects osteogenic differentiation.

Results

Compared with that in the other groups, alveolar bone destruction in the CKD + CP group was more severe. IS accumulated in the GCF of mice with CKD. IS activated the aryl hydrocarbon receptor (AhR) in vitro, inhibited MC3T3‐E1 cell osteogenic differentiation, caused changes in mitochondrial morphology, and activated the SLC7A11/GPX4 signaling pathway. An AhR inhibitor attenuated the aforementioned changes induced by IS.

Conclusions

IS activated the AhR/SLC7A11/GPX4 signaling pathway, inhibited osteogenesis in MC3T3‐E1 cells, and participated in alveolar bone resorption in CKD model mice through ferroptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alveolar Bone LossFerroptosisIndicanRenal Insufficiency, ChronicAnimalsMiceMaleMice, Inbred C57BLOsteogenesisReceptors, Aryl HydrocarbonX-Ray MicrotomographyCell DifferentiationHumansPhospholipid Hydroperoxide Glutathione PeroxidaseSignal TransductionDisease Models, AnimalPeriodontitis

Stichwörter der Autor:innen

alveolar bonearyl hydrocarbon receptorchronic kidney diseaseferroptosisindoxyl sulfate

Substanzen

IndicanReceptors, Aryl HydrocarbonPhospholipid Hydroperoxide Glutathione Peroxidaseglutathione peroxidase 4, mouse

Autor:innen und Institutionen

  • Department of Periodontology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • College of Stomatology, Shanghai Jiao Tong University, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai Research Institute of Stomato…
  • Department of Nephrology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Laboratory of Oral Microbiota and Systemic Diseases, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

ORCID-Profile: Huiwen Chen

Förderung

  • The National Natural Science Foundation of China
  • The Clinical Research Program of Health Care Industry, Shanghai Municipal Health Commission
  • The Data Sharing and Duplicated RCTs in Clinical Research
  • National Natural Science Foundation of China

Zitieren

APA

Chen, H., Zhou, Y., Liu, Y., Zhou, W., Xu, L., Shang, D., Ni, J., & Song, Z. (2025). Indoxyl sulfate exacerbates alveolar bone loss in chronic kidney disease through ferroptosis. Oral Diseases. https://doi.org/10.1111/odi.15050

Vancouver

Chen H, Zhou Y, Liu Y, Zhou W, Xu L, Shang D, et al. Indoxyl sulfate exacerbates alveolar bone loss in chronic kidney disease through ferroptosis. Oral Diseases. 2025. doi:10.1111/odi.15050

BibTeX
@article{Chen2025,
  author = {Chen, Huiwen and Zhou, Yining and Liu, Yingli and Zhou, Wei and Xu, Lina and Shang, Dihua and Ni, Jing and Song, Zhongchen},
  title = {Indoxyl sulfate exacerbates alveolar bone loss in chronic kidney disease through ferroptosis},
  journal = {Oral Diseases},
  year = {2025},
  doi = {10.1111/odi.15050}
}
Kostenlos starten →